Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Kim, Hark Kyun ^a,b   Kim, Joseph ^a   Korolevich, Susie ^c   Choi, Il Ju ^b   Kim, Chang Hee ^c   Munroe, David J ^c   Green, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b National Cancer Center   (South Korea)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DISSECTION; ENDOSCOPIC BIOPSY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY; STOMACH CANCER; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; GENE EXPRESSION REGULATION; GENETICS; LASER; METABOLISM; METHODOLOGY; MICRODISSECTION; PATHOLOGY; STOMACH TUMOR;

MESSENGER RNA;

COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASERS; MICRODISSECTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 79957845279     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-48     Document Type: Article

References (28)

1. Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. EC de Bruin S van de Pas EH Lips R van Eijk MM van der Zee M Lombaerts T van Wezel CA Marijnen JH van Krieken JP Medema CJ van de Velde PH Eilers LT Peltenburg, BMC Genomics 2005 6 142 10.1186/1471-2164-6-142 16225673
2. Impact of sample acquisition and linear amplification on gene expression profiling of lung adenocarcinoma: laser capture micro-dissection cell-sampling versus bulk tissue-sampling. EW Klee S Erdogan L Tillmans F Kosari Z Sun DA Wigle P Yang MC Aubry G Vasmatzis, BMC Med Genomics 2009 2 13 10.1186/1755-8794-2-13 19272143
3. Differential Trends in the Intestinal and Diffuse Types of Gastric Carcinoma in the United States, 1973-2000: Increase in the Signet Ring Cell Type. DE Henson C Dittus M Younes H Nguyen J Albores-Saavedra, Arch Pathol Lab Med 2004 128 765 770 15214826 (Pubitemid 38856886)
4. Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection. MS Wu YS Lin YT Chang CT Shun MT Lin JT Lin, World J Gastroenterol 2005 11 7405 7412 16437709
5. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. N Jinawath Y Furukawa S Hasegawa M Li T Tsunoda S Satoh T Yamaguchi H Imamura M Inoue H Shiozaki Y Nakamura, Oncogene 2004 23 40 6830 6844 10.1038/sj.onc.1207886 15273739 (Pubitemid 39280016)
6. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. Y Tsukamoto T Uchida S Karnan T Noguchi LT Nguyen M Tanigawa I Takeuchi K Matsuura N Hijiya C Nakada T Kishida K Kawahara H Ito K Murakami T Fujioka M Seto M Moriyama, J Pathol 2008 216 4 471 482 10.1002/path.2424 18798223
7. Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. HK Kim IJ Choi CG Kim HS Kim A Oshima Y Yamada Y Aaro K Nishio A Michalowski JE Green, Pharmacogenomics J 2010
8. A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients. HK Kim IJ Choi CG Kim HS Kim A Oshima A Michalowski JE Green, PLoS ONE 2011 6 2 16694 10.1371/journal.pone.0016694 21364753
9. DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. HK Kim IJ Choi HS Kim JH Kim E Kim IS Park JH Chun IH Kim IJ Kim HC Kang JH Park JM Bae JS Lee JG Park, Biochem Biophys Res Commun 2004 316 3 781 789 10.1016/j.bbrc.2004. 02.109 15033468 (Pubitemid 38372162)
10. Analysis of gene expression data using BRB-Array Tools. R Simon A Lam MC Li M Ngan S Menenzes Y Zhao, Cancer Inform 2007 2 11 17 (Pubitemid 47075796)
11. Gene sets expression comparison kit for BRB-ArrayTools. X Xu Y Zhao R Simon, Bioinformatics 2008 24 137 139 10.1093/bioinformatics/btm541 18006549
12. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. WK Leung J Yu FK Chan KF To MW Chan MP Ebert EK Ng SC Chung P Malfertheiner JJ Sung, J Pathol 2002 197 5 582 588 10.1002/path.1147 12210076
13. Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer. SQ Shi JT Cai JM Yang, World J Gastroenterol 2006 12 19 3119 3122 16718800
14. Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. K Kosriwong TR Menheniott AS Giraud P Jearanaikoon B Sripa T Limpaiboon, World J Gastroenterol 2011 17 12 1631 1641 10.3748/wjg.v17.i12.1631 21472131
15. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. ST Tay SH Leong K Yu A Aggarwal SY Tan CH Lee K Wong J Visvanathan D Lim WK Wong KC Soo OL Kon P Tan, Cancer Res 2003 63 12 3309 3316 12810664 (Pubitemid 36735888)
16. Relation of DNA ploidy to genetic aberrations detected by chromosomal CGH and FISH in gastric adenocarcinomas. T Furuya T Uchiyama A Adachi Y Chochi A Oga S Kawauchi K Ishiglo K Sasaki, Oncol Rep 2006 15 6 1491 1496 16685384
17. Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing. R Pinard A de Winter GJ Sarkis MB Gerstein KR Tartaro RN Plant M Egholm JM Rothberg JH Leamon, BMC Genomics 2006 7 216 10.1186/1471-2164-7-216 16928277
18. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. C Sakakura T Mori T Sakabe Y Ariyama T Shinomiya K Date A Hagiwara T Yamaguchi T Takahashi Y Nakamura T Abe J Inazawa, Genes Chromosomes Cancer 1999 24 299 305 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U 10092127 (Pubitemid 29115867)
19. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. XY Guan SB Fu JC Xia Y Fang JS Sham BD Du H Zhou S Lu BQ Wang YZ Lin Q Liang XM Li B Du XM Ning JR Du P Li JM Trent, Cancer Genet Cytogenet 2000 123 1 27 34 10.1016/S0165-4608(00)00306-X 11120330
20. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. MS Wu MC Chang SP Huang CC Tseng JC Sheu YW Lin CT Shun MT Lin JT Lin, Genes Chromosomes Cancer 2001 30 1 80 86 10.1002/1098-2264(2000)9999:9999<::AID-GCC1062>3.0.CO;2-R 11107179
21. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. H Takada I Imoto H Tsuda I Sonoda T Ichikura H Mochizuki T Okanoue J Inazawa, Cancer Sci 2005 96 2 100 110 10.1111/j.1349-7006.2005.00016.x 15723654 (Pubitemid 40425385)
22. Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Y Nakamura T Migita F Hosoda N Okada M Gotoh Y Arai M Fukushima M Ohki S Miyata K Takeuchi I Imoto H Katai T Yamaguchi J Inazawa S Hirohashi Y Ishikawa T Shibata, Int J Cancer 2009 125 8 1859 1867 10.1002/ijc.24538 19588488
23. Stromal gene expression predicts clinical outcome in breast cancer. G Finak N Bertos F Pepin S Sadekova M Souleimanova H Zhao H Chen G Omeroglu S Meterissian A Omeroglu M Hallett M Park, Nat Med 2008 14 5 518 527 10.1038/nm1764 18438415 (Pubitemid 351655218)
24. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. AK Witkiewicz A Dasgupta F Sotgia I Mercier RG Pestell M Sabel CG Kleer JR Brody MP Lisanti, Am J Pathol 2009 174 6 2023 2034 10.2353/ajpath.2009.080873 19411448
25. Integrative molecular concept modeling of prostate cancer progression. SA Tomlins R Mehra DR Rhodes X Cao L Wang SM Dhanasekaran S Kalyana-Sundaram JT Wei MA Rubin KJ Pienta RB Shah AM Chinnaiyan, Nat Genet 2007 39 1 41 51 10.1038/ng1935 17173048 (Pubitemid 46026500)
26. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? PB Dallas NG Gottardo MJ Firth AH Beesley K Hoffmann PA Terry JR Freitas JM Boag AJ Cummings UR Kees, BMC Genomics 2005 6 59 10.1186/1471-2164-6-59 15854232
27. Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study. E Arikawa Y Sun J Wang Q Zhou B Ning SL Dial L Guo J Yang, BMC Genomics 2008 9 328 10.1186/1471-2164-9-328 18620571
28. Cross platform microarray analysis for robust identification of differentially expressed genes. R Bosotti G Locatelli S Healy E Scacheri L Sartori C Mercurio R Calogero A Isacchi, BMC Bioinformatics 2007 8 Suppl 1 5 10.1186/1471-2105-8-S1-S5 18269699